Articles tagged with 'cancer' | University of Manchester

Cancer Research UK has announced today that universities across Scotland and England including the Cancer Research UK Manchester Centre are set to receive a multimillion-pound cash injection to train more doctors as clinician scientists, so they can …

Researchers based at Manchester University NHS Foundation Trust (MFT) and The University of Manchester, supported by the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC), have been awarded an …

A simple, safe and accurate test that identifies women with womb cancer from a sample taken from the vagina has been developed by clinician scientists from The University of Manchester.

Dr Raymond Schofield was awarded the 22nd annual Wiley Prize in Biomedical Sciences with Judith Kimble and Allan Spradling for their discovery of the stem cell niche, a localised environment that controls stem cell identity.

Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer which could revolutionise how the disease is diagnosed and treated in the future.

Researchers from the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC)  and University of Manchester have been instrumental in developing the first guideline for cancer screening in an …

The Eve Appeal, together with North West Cancer Research, will be awarding a three-year Fellowship to Dr Kelechi Njoku, from The University of Manchester, to develop a simpler and kinder test for detecting womb cancer.

Results from the largest ever review of clinical trials in cancer screening, prevention, and early detection (SPED) have been published.

Researchers are investigating how to stop triple negative breast cancer spreading, thanks to new funding from Breast Cancer Now.

The Christie NHS Foundation Trust and The University of Manchester have been awarded half a million pounds of funding from the Medical Research Council to produce a new immunotherapy for oesophageal cancer patients.

Friends and supporters of a University of Manchester student midwife diagnosed with a rare type of cancer are to raise money for charity on a 5K run in Media City.

Manchester researchers have developed a way to improve the accuracy of breast cancer genetic testing for women from Ashkenazi Jewish backgrounds.

The University of Manchester and Cancer Research UK have joined the PRIME-ROSE project, a Europe-wide effort to boost patient access to precision cancer medicine (PCM).

Manchester researchers have been awarded over £1 million by NHS England to explore the use of an innovative test for liver cancer, which will help patients access earlier care and potentially save lives.

A research programme called Living With and Beyond Cancer (LWBC) led by The Christie NHS Foundation Trust with The University of Manchester as part of the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre …

World-leading scientists, clinicians and operational staff are now moving into a new £150m cancer research centre at The Christie NHS Foundation Trust’s site on Wilmslow Road in Withington. The building is part of the Manchester Cancer …

A clinical trial project led by The University of Manchester has scooped the Bionow Healthcare Project of the Year Award for their innovative multi-drug pan-cancer platform trial that is helping to find new treatments for rare cancers.

Imaging researchers have taken a major step towards their ultimate goal of identifying cancers that are starved of oxygen so that altered treatment can be used to target them more effectively.

The search for new cancer treatments in Manchester is to receive a major funding investment of up to £3m, providing future hope for people diagnosed with the disease.

A rare variant of a protein present in nearly all human cells may hold the key to improving the effectiveness of breast cancer treatment, according to University of Manchester research funded by Breast Cancer Now.  

Cancer Research UK, The University of Manchester and Roche Products Ltd (‘Roche’), today (Wednesday 23rd), announce that they have opened a multi-drug, precision medicine trial for people with rare cancers who need more treatment options.

A groundbreaking initiative by Manchester and Kenyan researchers to bring world leading oesophageal cancer early detection and research to Kenya has received £2.6 million funding from the Government through the National Institute for Health …

A new study by scientists at PharmaKure -  a UK based pharmaceutical company spun out from The University of Manchester -is to examine blood biomarkers in Alzheimer’s disease patients.

Greater Manchester’s capacity to detect and diagnose cancers – and other health conditions which disproportionally affect the city region’s population – has been accelerated through a new strategic partnership.

Current international breast cancer surgery guidelines need urgent revision, according to a meta-analysis of 68 studies comprising 112,140 patients by University of Manchester researchers.

Professor Petra Hamerlik, one of the world’s leading experts in neuro-oncology, has joined The University of Manchester to develop translational brain tumour research as the first-ever The Brain Tumour Charity Chair of Translational …

Doctors could one day diagnose and characterise early stage small cell lung cancer (SCLC) with a simple blood test thanks to a transatlantic study led by CRUK Manchester Institute Cancer Biomarker Centre researchers at the University of Manchester …

High doses of drug called ifosfamide are the best way to treat a cancer of children which affects bones and soft tissues, compared to three other treatments, according to University of Manchester researchers.

A study of 1.3 million women in England has provided evidence to support the extension of cervical cancer screening intervals from three years to five years for those that have a negative screen result.

A ban of commercially available indoor tanning would substantially reduce deaths from melanoma, the most serious form of skin cancer, a study led  by University of Manchester researchers has concluded.